Page last updated: 2024-08-17

trifluoroethanol and Parkinson Disease

trifluoroethanol has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eliezer, D; Sung, YH1
Anderson, VL; Eliezer, D; Ramlall, TF; Rospigliosi, CC; Webb, WW1
Giehm, L; Lorenzen, N; Otzen, DE1
Du, HN; Hu, HY; Hu, J; Li, HT; Tang, L1

Reviews

1 review(s) available for trifluoroethanol and Parkinson Disease

ArticleYear
Assays for α-synuclein aggregation.
    Methods (San Diego, Calif.), 2011, Volume: 53, Issue:3

    Topics: alpha-Synuclein; Amyloid; Humans; Parkinson Disease; Reproducibility of Results; Research Design; Sodium Dodecyl Sulfate; Trifluoroethanol

2011

Other Studies

3 other study(ies) available for trifluoroethanol and Parkinson Disease

ArticleYear
Structure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region.
    Protein science : a publication of the Protein Society, 2018, Volume: 27, Issue:7

    Topics: Alcohols; alpha-Synuclein; Humans; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Propanols; Protein Aggregates; Protein Structure, Secondary; Trifluoroethanol

2018
Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Nov-02, Volume: 107, Issue:44

    Topics: alpha-Synuclein; Humans; Mutation; Parkinson Disease; Protein Structure, Secondary; Trifluoroethanol

2010
Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Biopolymers, 2002, Aug-05, Volume: 64, Issue:4

    Topics: alpha-Synuclein; Biopolymers; Circular Dichroism; gamma-Synuclein; Humans; In Vitro Techniques; Macromolecular Substances; Nerve Tissue Proteins; Parkinson Disease; Peptide Fragments; Protein Structure, Secondary; Spectrometry, Fluorescence; Synucleins; Trifluoroethanol

2002